Comparative survival analysis of platinum-based adjuvant chemotherapy for early-stage squamous cell carcinoma and adenocarcinoma of the lung

Keyphrases

• 5-year Survival 12%
• Adenocarcinoma 37%
• Adjusted Hazard Ratio 37%
• Baseline Characteristics 12%
• Completely Resected 12%
• Confidence Interval 37%
• Cox Regression Model 12%
• Curative Surgery 12%
• Early-stage Lung Cancer 50%
• Failure-free Survival 37%
• Inverse Probability of Treatment Weighting 25%
• Lung Adenocarcinoma 100%
• Lung Squamous Cell Carcinoma 100%
• Median Overall Survival 12%
• Non-small Cell Lung Cancer (NSCLC) 12%
• NSCLC Patients 25%
• Overall Survival 37%
• Randomized Controlled Study 12%
• Squamous Cell Carcinoma (SqCC) 37%
• Surgical Tumor Resection 12%
• Survival Analysis 100%
• Survival Benefit 12%
• Therapeutic Regimen 12%
• Treatment Failure 37%
• Well-balancing 12%

Medicine and Dentistry

• Adenocarcinoma 100%
• Adjuvant Chemotherapy 100%
• Cancer Surgery 12%
• Failure Free Survival 37%
• Hazard Ratio 37%
• Lung 100%
• Lung Cancer 12%
• Non-Small Cell Lung Cancer 50%
• Overall Survival 50%
• Proportional Hazards Model 12%
• Squamous Cell Carcinoma 100%
• Survival Analysis 100%
• Survival Rate 12%

Nursing and Health Professions

• Adenocarcinoma 100%
• Adjuvant Chemotherapy 100%
• Cancer Surgery 12%
• Confidence Interval 37%
• Failure Free Survival 37%
• Hazard Ratio 37%
• Lung Cancer 12%
• Overall Survival 50%
• Proportional Hazards Model 12%
• Squamous Cell Carcinoma 100%
• Survival Analysis 100%
• Survival Rate 12%
• Treatment Failure 37%